Genmab A/S (GMAB US)

Analysis

Health Care • Denmark

Genmab A/S operates as a biotechnology company. The Company specializes in development of antibody therapeutics for the treatment of cancer. Genmab serves customers worldwide.

Refresh

Company Presentation • 07 Oct 2026 14:00

EGM 2026 presentation

Company Presentation • 22 Aug 2026 14:00

Investor presentation

Company Presentation • 07 Aug 2026 00:00

Q2 2026

Company Presentation • 08 May 2026 00:00

Q1 2026

Company Presentation • 16 Feb 2026 15:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00